THANK YOU TO WDS 2024 Spring SPONSORS
Johnson & Johnson has been a world leader in the development of transformational medicines for immune-mediated diseases, establishing one of the strongest portfolios and pipelines in the industry. In addition to establishing anti-TNF-alpha therapy, we demonstrated the essential roles for inhibiting interleukin (IL)-12 and IL-23 in immune-mediated inflammatory diseases. We are committed to breaking new ground and expanding our research into challenging areas where high unmet medical needs remain. We have also expanded our portfolio beyond monoclonal antibodies to include novel, oral small molecules, and new biologic platforms, including the development of novel therapeutics that modify the Autoantibody pathway, which shows important potential in addressing multiple autoimmune disorders. | Regeneron |
Regeneron is a leading science-based
biopharmaceutical company that invents, develops
and commercializes medicines to treat serious medical
conditions.
Thank you to the following Silver Sponsors:
|
Thank you to our Bronze Sponsors!
|
CONTACT US   Wisconsin Dermatological Society |